(Q40162882)

18 September 2017

1 reference

title

Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation (English)

1 reference

18 September 2017

1 reference

1 reference

1 reference

1

Jerome Ritz

0 references

author name string

Ritz J

series ordinal

1

1 reference

18 September 2017

publication date

1 October 1983

1 reference

18 September 2017

October 1983

0 references

published in

Clinics in haematology

1 reference

18 September 2017

volume

12

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

813-832

1 reference

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Monoclonal antibodies. A new technique for producing serologic reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Autologous bone marrow transplantation in patients with adult acute leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Immune function in fully allogeneic mouse bone marrow chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

A unique cell surface antigen identifying lymphoid malignancies of B cell origin

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

The differentiation and function of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

A monoclonal antibody blocking human T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

A monoclonal antibody to human acute lymphoblastic leukaemia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate.

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2883%2980012-5

7 January 2021

10.1016/S0308-2261(83)80012-5

Identifiers

DOI

0 references

1 reference